Mechanism & significance
What changes in the microbe, and why
- Work with Fusarium oxysporum proposed a two-stage reduction pathway from Pt(IV) through Pt(II) to Pt(0), with different favorable conditions for the stages. It is a mechanistic model for a particular biological system. [1]
- In Citrobacter freundii JH, electron-transfer analysis implicated formate dehydrogenases, hydrogenases, and flavin-associated processes. Biogenic palladium promoted platinum reduction, linking two metals within the same electron-transfer system. [2]
- Engineered yeast displaying a hydrogenase produced elemental platinum particles from Pt(II). Microscopy and chemical analysis supported the identity of the recovered material. [3]
The broader picture
Platinum profiles need to separate microbial reduction, resistance, and engineered recovery. Fungi and bacteria can convert soluble platinum species into particles, while resistant cells can alter their physiology under exposure. None of these observations makes platinum an ordinary microbial cofactor. [1][2][4]
Experiments worth knowing
Hydrogenase-displaying yeast; anaerobic laboratory system
An engineered surface recovers platinum
Study design. A microbial display system was tested for conversion of dissolved Pt(II) into recoverable metal.
What they found. Elemental Pt particles formed, with their identity supported by X-ray photoelectron spectroscopy and electron microscopy. [3]
How to read it. This is an engineered biocatalyst demonstration. It should not be described as a natural platinum nutritional pathway.
Community & host evidence
Laboratory evolution of Cupriavidus metallidurans produced increased platinum resistance alongside genomic and transcriptomic changes, including membrane-related responses. Such adaptation illustrates how exposure selects cellular traits; it is not evidence that platinum benefits a diverse environmental or host microbiome. [4]
Exposure & chemical form
Pt(IV) salts, Pt(II) complexes, and elemental particles differ in accessibility and reaction pathway. The reduction bottleneck may change with oxidation state and electron supply. Conclusions from one dissolved salt cannot be assigned to all platinum materials or to a platinum-containing drug. [1][2]
What the evidence does not establish
Particle synthesis does not establish environmental persistence, catalytic performance, or clinical safety. Likewise, mutations found in a resistant lineage require additional functional work before each can be called a causal resistance mechanism. Recovery and tolerance should be evaluated with separate measurements. [4][3]
Open research questions
Questions suggested by the evidence and its limits.
Selected research
Sources supporting the numbered statements and study summaries above. Publication status is identified where a source reports trial results outside a peer-reviewed paper. This is a curated entry point, not a systematic review.
- Govender Y, Riddin T, Gericke M, Whiteley CG (2009). Bioreduction of platinum salts into nanoparticles: a mechanistic perspective. View source↩↩↩
- Wang J, Lin W, Chen Y, Hu Y, Luo Q (2021). Prompting the FDH/Hases-based electron transfers during Pt(IV) reduction mediated by bio-Pd(0). View source↩↩↩↩
- Ito R, Kuroda K, Hashimoto H, Ueda M (2016). Recovery of platinum(0) through the reduction of platinum ions by hydrogenase-displaying yeast. View source↩↩↩
- Ali MM, Provoost A, Maertens L, Leys N, Monsieurs P, Charlier D, Van Houdt R (2019). Genomic and Transcriptomic Changes that Mediate Increased Platinum Resistance in Cupriavidus metallidurans. View source↩↩↩↩